WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Belatacept ISE ALL - CMAP, Transplant recipients are characterized by HLA mismatch, Metabolic measures include New onset diabetes (NODM) incidence, Framingham risk score incorporates Total cholesterol, Central pathologist assesses Biopsy slides, GFR is used to assess Chronic Kidney Disease, Geographic region includes South America, Transplant recipients are characterized by Recent panel reactive antibodies (PRA), Diabetes causes End-Stage Renal Disease (ESRD), Myocardial Infarction can be Fatal, Geographic region includes North America, Framingham risk score incorporates Systolic pressure, Gender includes Male, Cardiovascular measures include Blood pressure, Efficacy endpoint includes Renal Function, Acute rejection occurs at a Rate, GFR can be thresholded at 60 mL/min/1.73 m^2, Transplant donors are characterized by Donor condition, Immunosuppressive regimen includes Mycophenolate Mofetil (MMF), Study design incorporates Immunosuppressive regimen, Transplant donors are characterized by Baseline biopsy fibrosis